Form 4 for SRTA Strata Critical Medical, Inc.
Accepted 2024-11-15 00:00:00 ET · period of report 2024-11-14 · accession 0001779128-24-000132 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-15 | 2024-11-14 | SRTA | WIESENTHAL ROBERT S | CEO, Dir, 10% | S - Sale | $3.22 | -2.10M | 4.81M | -30% | -$6.76M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A common stock, $0.0001 par value per share | 2024-11-14 | S | D | 2,100,000 | $3.22 | 4,812,892 | D | — | — | (F1) Following the reported transactions, the number of shares of Class A Common Stock of the Issuer beneficially owned by the Reporting Person, 8,749,588 (inclusive of exercisable stock options and restricted stock units vesting with 60 days of the final transaction date), plus the number of shares of Class A Common Stock of the Issuer underlying the Reporting Person's outstanding unvested equity awards (inclusive of 1,971,428 unvested performance-based restricted stock units and 1,249,696 unvested time-based restricted stock units that are not vesting within 60 days of the reported transaction), is equal to 11,970,712 shares of Class A Common Stock of the Issuer in the aggregate. |